Switzerland· 54845049

Cytosar Solution

A cytarabine product containing cytarabinum, registered in Switzerland and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC L01BC01

Checked against BAG Spezialitätenliste (Switzerland) on September 12, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about cytarabinumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Cytarabine is registered in 16 of 19 countries.

Countries holding a registration under ATC L01BC01 (cytarabine), each read from that country’s own register.

This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
9 of them publish a price we can compare per daily dose

Search cytarabine products by name

Cytarabine · ATC L01BC01

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

BAG Spezialitätenliste (Switzerland)

Active substance: cytarabinum
Manufacturer: —
Country: Switzerland (CH)
ATC code: L01BC01
ATC class: Cytarabine
Swissmedic category: A
Reimbursed: Yes
Source register: BAG Spezialitätenliste (Switzerland)
Last checked: September 12, 2026

Packs & prices · 1

1 priced

gtin
7680548450494
Onco-Tain 20 ml
CHF 75.35

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

415 interactions on record for cytarabine.

Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check cytarabine against other medicines How interaction checks work

Cytarabine · interactions on record

415 records

35 severe
113 moderate
16 minor
251 info

Most severe, free to view

MipomersenC10AX11severe
LomitapideC10AX12severe
CladribineL01BB04severe
PexidartinibL01EX15severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cytarabine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cytarabine products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Alexan, Cytarabin Accord
Belgium · Cytarabine Accord Healthcare, Cytarabine Fresenius Kabi
Bulgaria · Алексан, Цитарабин Акорд
Cyprus · Cytarabine Accord, Cytarabine Pfizer Hellas
Czechia · Alexan, Cytarabine Accord
Germany · Ara-Cell, Cytarabin Accord
Denmark · Cytarabin Fresenius Kabi, Cytarabine Accord
Estonia · Cytarabine Accord, Cytarabine Kabi
Spain · Citarabina Accord, Citarabina Kabi
Finland · Cytarabine Accord, Cytarabine Accord Healthcare
France · Aracytine, Cytarabine Accord
United Kingdom (Northern Ireland) · Cytarabine Accord Healthcare, Cytarabine Fresenius Kabi Oncology
Greece · Aracytin, Citabion
Croatia · Cytosar
Hungary · Alexan, Cytarabine Accord
Ireland · Cytarabine, Cytarabine Accord Healthcare Ireland
Iceland · Cytarabin Fresenius Kabi, Cytarabine Pfizer
Italy · Aracytin, Citarabina Accord
Lithuania · Cytarabine Accord, Cytarabine Kabi
Luxembourg · Cytosar
Latvia · Cytarabine Accord, Cytarabine Kabi
Malta · Cytarabine Accord Healthcare, Cytarabine Pfizer Hellas
Netherlands · Cytarabine Accord, Cytarabine Fresenius Kabi
Norway · Cytarabin Fresenius Kabi, Cytarabine Accord
Poland · Alexan, Cytarabina Accord
Portugal · Citaloxan, Citarabina Accord
Romania · Citarabină Accord, Citarabina Kabi
Sweden · Cytarabin Fresenius Kabi, Cytarabin Hikma
Slovenia · Citarabin Accord, Cytosar
Slovakia · Cytarabine Accord, Cytosar

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/63a86d21-d2b8-4c01-8886-fd2534637917
GET /v1/drugs/63a86d21-d2b8-4c01-8886-fd2534637917?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "cytarabinum 2000 mg",
  "valid_from": "2015-10-01",
  "limitations": null,
  "galenic_form": "Inj Lös 2 g/20ml",
  "therapeutic_area": null,
  "sl_inclusion_date": "2015-10-01",
  "self_retention_pct": 10
}

API reference MCP server Plans

See everything about cytarabine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console